文献速递头颈MR

鼻咽癌淋巴结转移分期:MRI上应选用哪种方法测量淋巴结最大径

Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI?
PubMed 文献 · Clin Radiol · 2018-04-07

研究分析712例鼻咽癌患者的MRI,比较四种测量转移性颈部淋巴结最大径的方法,并与淋巴结体积及生存结局相关分析。方法4(轴位/冠状位测量单发、融合及连续淋巴结)与淋巴结体积相关性最强(R=0.84),且是OS、DSS和DMFS的唯一独立淋巴结测量指标。

要点

  • 测量淋巴结最大径时,应纳入单发、融合及连续淋巴结,并在显示最大径的平面上测量。
  • 方法4与淋巴结体积相关性最强(R=0.84),优于方法3(R=0.77)、方法2(R=0.70)和方法1(R=0.69)。
  • 方法4是OS(p=0.008)、DSS(p<0.001)和DMFS(p<0.001)的唯一独立淋巴结测量指标。

核心结论

  • 获取用于分期的淋巴结最大径的最佳方法,是不仅在轴位/冠状位测量单发和融合淋巴结,还纳入连续淋巴结,并在显示最大径的平面上测量。

研究设计与样本

  • 研究分析了712例鼻咽癌患者的MRI检查,比较四种测量转移性颈部淋巴结最大径的方法,并将最大径与淋巴结体积及生存结局进行相关分析。

诊断标准与关键数值

  • 方法1:在轴位平面上测量单个淋巴结的最大径。
  • 方法2:在轴位/冠状位平面上测量单个淋巴结的最大径。
  • 方法3:在轴位/冠状位平面上测量单个和/或融合淋巴结的最大径。
  • 方法4:在轴位/冠状位平面上测量单个和/或融合和/或连续淋巴结的最大径。
  • 方法4与淋巴结体积相关性最强(R=0.84),其次为方法3(R=0.77)、方法2(R=0.70)和方法1(R=0.69)。

临床应用与阅片要点

  • 在MRI上测量鼻咽癌转移性淋巴结最大径用于分期时,应采用方法4,即纳入单发、融合及连续淋巴结,并在显示最大径的平面上测量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate four methods to measure the maximum dimension (MD) of metastatic neck nodes and correlate with clinical outcome in nasopharyngeal carcinoma (NPC).

MATERIALS AND METHODS: Magnetic resonance imaging (MRI) examinations of 712 NPC patients were analysed. MD measurements using methods 1, 2, 3, and 4 were obtained from a single node in the axial plane; a single node in the axial/coronal plane; a single and/or confluent nodes in the axial/coronal plane; and a single and/or confluent and/or contiguous nodes in the axial/coronal plane, respectively. MDs obtained from the four methods were correlated with nodal volume (NV) using Pearson's correlation test. MDs obtained from the four methods, T and N stages, age, gender, and treatment were correlated with overall survival (OS), disease-specific survival (DSS), distant metastases free survival (DMFS), and regional relapse-free survival (RRFS) using cox regression.

RESULTS: Method 4 (R: 0.84) had the strongest correlation with NV followed by method 3 (R: 0.77), method 2 (R: 0.70) and method 1(R: 0.69). Method 4 was the only independent nodal measurement of OS, DSS, and DMFS (p-values = 0.008, <0.001 and <0.001, respectively). None of the MD methods was an independent measurement of RRFS.

CONCLUSIONS: The best method to obtain the MD for staging incorporates not only single and confluent, but also contiguous metastatic nodes measured in the plane with the MD.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ai QY, King AD, Mo FKF, et al. Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI? Clin Radiol. 2018. PMID: 29636188. doi:10.1016/j.crad.2017.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。